Skip to ContentSkip to Navigation
Research Zernike (ZIAM) Polymer Chemistry and Bioengineering Crielaard Group

Publications

2017

Meng, Z., Yang, J., Liu, Q., de Vries, J. W., Gruszka, A., Rodriguez-Pulido, A., Crielaard, B. J., Kros, A., & Herrmann, A. (2017). Efficient Fusion of Liposomes by Nucleobase Quadruple-Anchored DNA. Chemistry, 23(39), 9391-9396. https://doi.org/10.1002/chem.201701379
Crielaard, B. J., Lammers, T., & Rivella, S. (2017). Targeting iron metabolism in drug discovery and delivery. Nature Reviews Drug Discovery, 16(6), 400-423. https://doi.org/10.1038/nrd.2016.248

2016

Chessa, R., Gupta, R., Crielaard, B. J., Casu, C., Feldman, R., & Rivella, S. (2016). LACK OF BETA-1 INTEGRIN LIMITS STRESS EYTHOPOIESIS AND SPLENOMEGALY IN BETA-THALASSEMIA. American Journal of Hematology, 91(3), E223-E223. http://www.bloodjournal.org/content/126/23/2196?sso-checked=true

2015

Chessa, R., Gupta, R., Crielaard, B. J., Casu, C., Feldman, R., & Rivella, S. (2015). Lack of Beta-1 Integrin Limits Stress Erythropoiesis and Splenomegaly in Beta-Thalassemia. Blood, 126(23).
Oikonomidou, P. R., Casu, C., Yang, Z., Crielaard, B., Shim, J. H., Rivella, S., & Vogiatzi, M. G. (2015). Polycythemia is associated with bone loss and reduced osteoblast activity in mice. Osteoporosis International, 27(4), 1559-1568. https://doi.org/10.1007/s00198-015-3412-7

2014

Deckers, R., Sprinkhuizen, S. M., Crielaard, B. J., Ippel, J. H., Boelens, R., Bakker, C. J. G., Storm, G., Lammers, T., & Bartels, L. W. (2014). Absolute MR thermometry using nanocarriers. Contrast Media & Molecular Imaging, 9(4), 283-290. https://doi.org/10.1002/cmmi.1572
Crielaard, B., Chessa, R., Gupta, R., Casu, C., & Rivella, S. (2014). Beta-1 Integrin Controls Homing and Expansion of Erythroid Cells in Stress Erythropoiesis and beta-Thalassemia. Blood, 124(21).
Gardenghi, S., Renaud, T. M., Meloni, A., Casu, C., Crielaard, B. J., Bystrom, L. M., Greenberg-Kushnir, N., Sasu, B. J., Cooke, K. S., & Rivella, S. (2014). Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood, 123(8), 1137-1145. https://doi.org/10.1182/blood-2013-08-521625
Ozbakir, B., Crielaard, B. J., Metselaar, J. M., Storm, G., & Lammers, T. (2014). Liposomal corticosteroids for the treatment of inflammatory disorders and cancer. Journal of controlled release : official journal of the Controlled Release Society, 190, 624-636. https://doi.org/10.1016/j.jconrel.2014.05.039
Quan, L., Zhang, Y., Crielaard, B. J., Dusad, A., Lele, S. M., Rijcken, C. J. F., Metselaar, J. M., Kostková, H., Etrych, T., Ulbrich, K., Kiessling, F., Mikuls, T. R., Hennink, W. E., Storm, G., Lammers, T., & Wang, D. (2014). Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. Acs Nano, 8(1), 458-466. https://doi.org/10.1021/nn4048205
Gupta, R., Crielaard, B., Mukherjee, P., Theurl, I., Casu, C., & Rivella, S. (2014). Stress Erythropoiesis Is Associated with Changes in the Transcriptome of Central Macrophages. Blood, 124(21).
Crielaard, B. J., & Rivella, S. (2014). β-Thalassemia and Polycythemia vera: Targeting chronic stress erythropoiesis. International journal of biochemistry & cell biology, 51, 89-92. https://doi.org/10.1016/j.biocel.2014.03.029

2013

Ramos, P., Casu, C., Gardenghi, S., Breda, L., Crielaard, B. J., Guy, E., Marongiu, M. F., Gupta, R., Levine, R. L., Abdel-Wahab, O., Ebert, B. L., Van Rooijen, N., Ghaffari, S., Grady, R. W., Giardina, P. J., & Rivella, S. (2013). Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia. Nature Medicine, 19(4), 437-45. https://doi.org/10.1038/nm.3126

2012

Tiebosch, I. A. C. W., Crielaard, B. J., Bouts, M. J. R. J., Zwartbol, R., Salas-Perdomo, A., Lammers, T., Planas, A. M., Storm, G., & Dijkhuizen, R. M. (2012). Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats. Journal of Neurochemistry, 123 Suppl 2, 65-74. https://doi.org/10.1111/j.1471-4159.2012.07945.x
Coimbra, M., Crielaard, B. J., Storm, G., & Schiffelers, R. M. (2012). Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines. Journal of controlled release : official journal of the Controlled Release Society, 160(2), 232-8. https://doi.org/10.1016/j.jconrel.2011.10.019
Crielaard, B. J., Lammers, T., Schiffelers, R. M., & Storm, G. (2012). Drug targeting systems for inflammatory disease: one for all, all for one. Journal of controlled release : official journal of the Controlled Release Society, 161(2), 225-34. https://doi.org/10.1016/j.jconrel.2011.12.014
Crielaard, B. J., Rijcken, C. J. F., Quan, L., van der Wal, S., Altintas, I., van der Pot, M., Kruijtzer, J. A. W., Liskamp, R. M. J., Schiffelers, R. M., van Nostrum, C. F., Hennink, W. E., Wang, D., Lammers, T., & Storm, G. (2012). Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angewandte Chemie - International Edition, 51(29), 7254-8. https://doi.org/10.1002/anie.201202713
Crielaard, B. J., van der Wal, S., Le, H. T., Bode, A. T. L., Lammers, T., Hennink, W. E., Schiffelers, R. M., Fens, M. H. A. M., & Storm, G. (2012). Liposomes as carriers for colchicine-derived prodrugs: vascular disrupting nanomedicines with tailorable drug release kinetics. European Journal Pharmaceutical Sciences, 45(4), 429-35. https://doi.org/10.1016/j.ejps.2011.08.027
Cittadino, E., Ferraretto, M., Torres, E., Maiocchi, A., Crielaard, B. J., Lammers, T., Storm, G., Aime, S., & Terreno, E. (2012). MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate. European Journal Pharmaceutical Sciences, 45(4), 436-41. https://doi.org/10.1016/j.ejps.2011.08.022
Leonard, F., Ali, H., Collnot, E-M., Crielaard, B. J., Lammers, T., Storm, G., & Lehr, C-M. (2012). Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. ALTEX: Alternatives to Animal Experimentation, 29(3), 275-85. https://doi.org/10.14573/altex.2012.3.275
Vader, P., Crielaard, B. J., van Dommelen, S. M., van der Meel, R., Storm, G., & Schiffelers, R. M. (2012). Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles. Journal of controlled release : official journal of the Controlled Release Society, 160(2), 211-6. https://doi.org/10.1016/j.jconrel.2011.09.080

2011

Crielaard, B. J., van der Wal, S., Lammers, T., Le, H. T., Hennink, W. E., Schiffelers, R. M., Storm, G., & Fens, M. H. (2011). A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy. International Journal of Nanomedicine, 6, 2697-703. https://doi.org/10.2147/IJN.S24450
Crielaard, B. J., Yousefi, A., Schillemans, J. P., Vermehren, C., Buyens, K., Braeckmans, K., Lammers, T., & Storm, G. (2011). An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. Journal of controlled release : official journal of the Controlled Release Society, 156(3), 307-14. https://doi.org/10.1016/j.jconrel.2011.07.023
Crielaard, B. J., Lammers, T., Morgan, M. E., Chaabane, L., Carboni, S., Greco, B., Zaratin, P., Kraneveld, A. D., & Storm, G. (2011). Macrophages and liposomes in inflammatory disease: Friends or foes? International Journal of Pharmaceutics, 416(2), 499-506. https://doi.org/10.1016/j.ijpharm.2010.12.045

2009

Neut, D., Kluin, O. S., Crielaard, B., van der Mei, H. C., Busscher, H. J., & Grijpma, D. W. (2009). A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthopaedica, 80(5), 514-519. https://doi.org/10.3109/17453670903350040
Last modified:13 October 2015 3.48 p.m.